Latest Breaking News On - Partner milestone payments upon inclusion - Page 1 : comparemela.com

Results Demonstrate Significant Reductions in LDL-C, hsCRP and Cardiovascular Risk in Patients Who Are Unable to Maximize or Tolerate a Statin.

Joanne foodySheldon koenigExchange commissionWorld congressEsperion corporate communicationsReduced riskMajor adverse cardiovascular eventsSignificantly reduced riskMyocardial infarctionCoronary revascularizationBroader outcomes benefitsSecondary prevention comparedWhose outcomes studies were limitedOnly secondary preventionDetailed results simultaneously publishedNew england journal